Preoperative comorbidities and relationship of comorbidities with postoperative complications in patients undergoing transurethral prostate resection

Journal of Urology

Volumn 185, Issue 4, 2011, Pages 1374-1378

  Hong, Jeong Yeon ^a,b   Yang, Seung Chul ^b   Ahn, Seohui ^b   Kil, Hae Keum ^b  

^a University of Ulsan College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

age groups; comorbidity; postoperative complications; prostate; transurethral resection of prostate

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLEEDING; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DYSURIA; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART VALVE REPLACEMENT; HEMATURIA; HUMAN; HYPERTENSION; INCIDENCE; INFECTION; INTRAOPERATIVE PERIOD; KIDNEY INJURY; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; NEOPLASM; PARKINSON DISEASE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPSIS; SPINE DISEASE; THYROID DISEASE; TRANSURETHRAL RESECTION; UNIVERSITY HOSPITAL;

AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSTATIC HYPERPLASIA; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 79952708831     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.11.086     Document Type: Article

References (23)

1. Arrighi HM, Metter EJ, Guess HA et al: Natural history of benign prostatic hyperplasia and risk of prostatectomy. The Baltimore Longitudinal Study of Aging. Urology 1991; 38: 4.
2. McConnell JD, Bruskewitz R, Walsh P et al: The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group. N Engl J Med 1998; 338: 557.
3. Concato J, Horwitz RI, Feinstein AR et al: Problems of comorbidity in mortality after prostatectomy. JAMA 1992; 267: 1077.
4. Holman CD, Wisniewski ZS, Semmens JB et al: Mortality and prostate cancer risk in 19,598 men after surgery for benign prostatic hyperplasia. BJU Int 1999; 84: 37.
5. Hahn RG, Farahmand BY, Hallin A et al: Incidence of acute myocardial infarction and cause-specific mortality after transurethral treatments of prostatic hypertrophy. Urology 2000; 55: 236.
6. Lu-Yao GL, Barry MJ, Chang CH et al: Transurethral resection of the prostate among Medicare beneficiaries in the United States: time trends and outcomes. Prostate Patient Outcomes Research Team (PORT). Urology 1994; 44: 692.
7. Chen YK and Lin HC: Association between urologists' caseload volume and in-hospital mortality for transurethral resection of prostate: a nationwide population-based study. Urology 2008; 72: 329.
8. Reich O, Gratzke C, Bachmann A et al: Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. Urology Section of the Bavarian Working Group for Quality Assurance. J Urol 2008; 180: 246.
9. Jeldres C, Isbarn H, Capitanio U et al: Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia. J Urol 2009; 182: 626.
10. Charlson ME, Pompei P, Ales KL et al: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373.
11. Wei JT, Calhoun E and Jacobsen SJ: Urologic Diseases in America project: benign prostatic hyperplasia. J Urol 2005; 173: 1256.
12. Lee E, Yoo KY, Kim Y et al: Prevalence of lower urinary tract symptoms in Korean men in a community- based study. Eur Urol 1998; 33: 17.
13. Platz EA, Kawachi I, Rimm EB et al: Race, ethnicity and benign prostatic hyperplasia in the Health Professionals Follow-Up Study. J Urol 2000; 163: 490.
14. Tsukamoto T, Kumamoto Y, Masumori N et al: Prevalence of prostatism in Japanese men in a community-based study with comparison to a similar American study. J Urol 1995; 154: 391.
15. Sagnier PP, Girman CJ, Garraway M et al: International comparison of the community prevalence of symptoms of prostatism in four countries. Eur Urol 1996; 29: 15.
16. Takao T, Tsujimura A, Kiuchi H et al: Urological surgery in patients aged 80 years and older: a 30-year retrospective clinical study. Int J Urol 2008; 15: 789.
17. Madersbacher S, Lackner J, Brössner C et al: Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases. Prostate Study Group of the Austrian Society of Urology. Eur Urol 2005; 47: 499.
18. Mebust WK, Holtgrewe HL, Cockett AT et al: Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989; 141: 243.
19. Smith R, Osterweil D and Ouslander JG: Perioperative care in the elderly urologic patient. Urol Clin North Am 1996; 23: 27.
20. Wasson JH, Bubolz TA, Lu-Yao GL et al: Transurethral resection of the prostate among Medicare beneficiaries: 1984 to 1997. Patient Outcomes Research Team for Prostatic Diseases. J Urol 2000; 164: 1212.
21. Seagroatt V: Mortality after prostatectomy: selection and surgical approach. Lancet 1995; 346: 1521.
22. Holtgrewe HL and Valk WL: Factors influencing the mortality and morbidity of transurethral prostatectomy: a study of 2,015 cases. J Urol 1962; 87: 450.
23. Melchior J, Valk WL, Foret JD et al: Transurethral prostatectomy: computerized analysis of 2,223 consecutive cases. J Urol 1974; 112: 634.